ÂÜÀòÂÒÂ×

Michael Dyrgaard Lundov has extensive work experience in the medical writing field. Michael Dyrgaard is currently a Senior Medical Writer at Nykode Therapeutics, where they started in May 2022. Prior to this role, they worked at Orphazyme A/S as a Manager of Medical Writing from February 2022 to March 2022, and as a Senior Medical Writer from August 2020 to February 2022. Before Orphazyme A/S, Michael worked at Novo Nordisk, where they held various positions including Senior Event Adjudication professional from September 2018 to August 2020, Senior Medical Writer from March 2018 to September 2018, and Medical Writer from May 2014 to March 2018. Michael Dyrgaard also has experience as a Senior researcher at the National Allergy Research Centre from June 2007 to May 2014, and as a Forskningsassistent at Danmarks Fødevareforskning from June 2006 to December 2006.

Michael Dyrgaard Lundov earned their Ph.D. degree from Københavns Universitet - University of Copenhagen, where they studied from 2007 to 2011. Prior to that, they completed their Cand.scient degree in Biology at the same university from 2000 to 2006.